TC
PLRX icon

Torno Capital’s Pliant Therapeutics PLRX Stock Holding History

Torno Capital’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$401K Buy
351,445
+1,445
+0.4% +$1.76K 0.01% 50
2026
Q1 		$441K Buy
350,000
+30,000
+9% +$37.9K 0.06% 43
2025
Q4 		$390K Buy
320,000
+189,084
+144% +$284K 0.04% 70
2025
Q3 		$194K Buy
+130,916
New +$200K 0.01% 71

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Torno Capital's PLRX Position: Q2 2026 in Review

Torno Capital increased its Pliant Therapeutics (PLRX) stake by 0.41% in Q2 2026, buying an estimated $1.76K and bringing the position to 351,445 shares worth $401K. The position accounts for 0.01% of the portfolio, ranked #50.

Torno Capital first reported a position in PLRX in Q3 2025 and has held it in 4 quarters since. The position peaked at $441K in Q1 2026. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Torno Capital held 351,445 shares of Pliant Therapeutics worth $401K as of Q2 2026.
  • Torno Capital bought 1,445 Pliant Therapeutics shares in Q2 2026, an estimated $1.76K.
  • Pliant Therapeutics made up 0.01% of Torno Capital's portfolio in Q2 2026, its #50 holding.
  • Torno Capital first reported a position in Pliant Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Torno Capital's Pliant Therapeutics position peaked at $441K in Q1 2026.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Torno Capital's 13F filing for Q2 2026, filed 14 Aug 2026.